China: Advancing manufacturing for a new era

China’s entrepreneurial culture, large end market and robust supply-chain are unique factors that will help advance its manufacturing industry. Together with the government’s strong commitment, we are optimistic that many Chinese companies will emerge as tomorrow’s global leaders across multiple sectors.

Eastspring China

China’s call to advance its domestic manufacturing industry at the October 2020 Plenum came amid the COVID-19 pandemic outbreak and heightened US-China geopolitical tensions. The early days of the pandemic had wreaked havoc in global supply chains and had raised questions in both developed and emerging countries on whether there was a need to locate production facilities closer to home. At that time, the Trump administration had succeeded in cutting off most of China’s access to specialised semiconductor chips and equipment that were needed to build 5G telecommunication networks, hobbling China’s 5G ambition. 

The odds in China’s favour

As China seeks to advance its manufacturing industry, a number of factors positions it well. Globally, only a handful of countries has been responsible for the bulk of new inventions. Although Japan and the US still account for the largest shares of global patent applications at 26% and 19% respectively, China’s share has risen from almost zero in 2005 to 10% in 2018, in line with Germany’s1.

Meanwhile, an entrepreneurial culture, as measured by attitudes towards entrepreneurial risk, reigns high in China. See Fig. 1. Historically, a strong entrepreneurial culture has been correlated to the establishment of start-ups, unicorns and tech-hubs in other countries.

Fig. 1. Trends in attitudes towards entrepreneurial risk, selected countries (2008 – 2020)

china-advancing-manufacturing-for-a-new-era-chart-01

China also benefits from having a large end market (which helps to drive unit costs down), a robust supply chain eco-system as well as a relatively well-developed infrastructure. Fig 2. shows the uniqueness of China’s manufacturing industry where it can offer better technologies compared to low-cost emerging countries, and at the same time, a lower cost option compared to developed countries.

Fig. 2. Global Trade Specialisation Coefficient vs GDP per capita

china-advancing-manufacturing-for-a-new-era-chart-02

The ability of China to gain export market share during the COVID-19 pandemic reflects the resilience of China’s supply chains. China’s share of global exports reached 17.2%2 in April 2020 and is reported to have hit a record high in the seven months to July 2020, boosted by global demand for its healthcare equipment and technology products3. For the full year of 2020, China’s exports grew 3.6%yoy and its trade surplus reached a five-year high (USD585b). Meanwhile, China’s competitiveness in the smartphone handset and telecommunications equipment industries is widely acknowledged and potentially presents a playbook for an increasing number of industries to become more competitive. Selected industrial companies within the Factory Automation supply chain have recently indicated that a Factory Automation upcycle is emerging in China, partly aided by accelerating import substitution and an increase in Electric Vehicle platforms4.

Industrial Revolution 4.0

The desire by the Chinese authorities to lift the value add and quality of China’s manufacturing output could probably not come at a more opportune time, as we are in the middle of the Fourth Industrial Revolution.

The fortunes of economies have waxed and waned across the different industrial revolutions. In the First Industrial Revolution, rural, agricultural societies transformed themselves into industrialised and urban economies by harnessing steam and water power to mechanise production. In the Second Industrial Revolution, countries leveraged electric power for mass production. In the 1960s and 1970s, Japan and Germany transferred light industry, textile and other labour-intensive processing industries to the Four Asian Dragons (Hong Kong, South Korea, Singapore and Taiwan) as well as selected Latin American countries. In the 1980s, developed countries such as Europe, the United States and Japan, as well as the newly industrialised countries in Asia (including the Four Asian Dragons moved labour-intensive, low-tech industries to developing countries such as China. China then became known as the “world’s factory”.

In the past decade, as China’s demographic dividend diminished, rising wages and anti-dumping duties led the textile, electronics, tires and other processing trade sectors to shift to Vietnam, India, Thailand, Cambodia and other Southeast Asian countries.

The Fourth Industrial Revolution brings technology breakthroughs in artificial intelligence, robotics, Internet of Things, 3-D printing and quantum computing. We believe that China would be able to leverage these innovative and emerging technologies to raise the quality and competitiveness of its manufacturing industry.

The new “Made in China”

In 2020, the Chinese government rolled out subsidies, tax benefits and targeted credit support to help develop the auto, New Energy Vehicles, 5G, integrated circuit, medical services/equipment and clean energy sectors. For example, USD100bn-plus worth of subsidies were made available to chip-related companies. Top universities in China also upgraded their engineering curriculum.

In March 2020, the Chinese government extended tax benefits and subsidies for New Energy Vehicles (hybrid and electric) by another two years. During 2020, China’s National Energy Administration (NEA) and the National Development and Reform Commission (NDRC) had also pledged to spend more than USD360 billion developing renewable energy and creating 13 million jobs in the sector.

There has also been rising co-operation within the medical device sector among companies, research institutes, universities and medical institutions to lift innovation, shorten the R&D process and accelerate the industrialisation of innovative medical devices. In the medical aesthetics sector, the top three local players already account for 42.4% of China’s Hyaluronic Acid filler market.

We expect the state, provincial and local governments to extend further policy support and to encourage greater R&D spending in key sectors. We continue to look for opportunities within the new energy, industrial automation, construction machinery, medical devices, automobiles and home appliances sectors and are optimistic that many Chinese companies will emerge to become tomorrow’s global leaders.   

This is the third of six articles in Eastspring’s 2021 Asian Expert Series. In this new series which focuses on China, our investment teams offer insights into the opportunities and challenges facing China as it rolls out its 14th Five-Year Plan.

Click here to read other articles in our Asian Expert Series. 

For Use with Professional Clients / Qualified Investors Only. Not Approved for Further Distribution or Use with the General Public.

The information and views expressed herein do not constitute an offer or solicitation to deal in shares of any securities or financial instruments and it is not intended for distribution or use by anyone or entity located in any jurisdiction where such distribution would be unlawful or prohibited. The information does not constitute investment advice or an offer to provide investment advisory or investment management service or the solicitation of an offer to provide investment advisory or investment management services in any jurisdiction in which an offer or solicitation would be unlawful under the securities laws of that jurisdiction.


Past performance and the predictions, projections, or forecasts on the economy, securities markets or the economic trends of the markets are not necessarily indicative of the future or likely performance of Eastspring Investments or any of the strategies managed by Eastspring Investments. An investment is subject to investment risks, including the possible loss of the principal amount invested. Where an investment is denominated in another currency, exchange rates may have an adverse effect on the value price or income of that investment. Furthermore, exposure to a single country market, specific portfolio composition or management techniques may potentially increase volatility.


Any securities mentioned are included for illustration purposes only. It should not be considered a recommendation to purchase or sell such securities. There is no assurance that any security discussed herein will remain in the portfolio at the time you receive this document or that security sold has not been repurchased.


The information provided herein is believed to be reliable at time of publication and based on matters as they exist as of the date of preparation of this report and not as of any future date. Eastspring Investments undertakes no (and disclaims any) obligation to update, modify or amend this document or to otherwise notify you in the event that any matter stated in the materials, or any opinion, projection, forecast or estimate set forth in the document, changes or subsequently becomes inaccurate. Eastspring Investments personnel may develop views and opinions that are not stated in the materials or that are contrary to the views and opinions stated in the materials at any time and from time to time as the result of a negative factor that comes to its attention in respect to an investment or for any other reason or for no reason. Eastspring Investments shall not and shall have no duty to notify you of any such views and opinions. This document is solely for information and does not have any regard to the specific investment objectives, financial or tax situation and the particular needs of any specific person who may receive this document.


Eastspring Investments Inc. (Eastspring US) primary activity is to provide certain marketing, sales servicing, and client support in the US on behalf of Eastspring Investment (Singapore) Limited (“Eastspring Singapore”). Eastspring Singapore is an affiliated investment management entity that is domiciled and registered under, among other regulatory bodies, the Monetary Authority of Singapore (MAS). Eastspring Singapore and Eastspring US are both registered with the US Securities and Exchange Commission as a registered investment adviser. Registration as an adviser does not imply a level of skill or training. Eastspring US seeks to identify and introduce to Eastspring Singapore potential institutional client prospects. Such prospects, once introduced, would contract directly with Eastspring Singapore for any investment management or advisory services. Additional information about Eastspring Singapore and Eastspring US is also is available on the SEC’s website at www.adviserinfo.sec. gov.


Certain information contained herein constitutes "forward-looking statements", which can be identified by the use of forward-looking terminology such as "may", "will", "should", "expect", "anticipate", "project", "estimate", "intend", "continue" or "believe" or the negatives thereof, other variations thereof or comparable terminology. Such information is based on expectations, estimates and projections (and assumptions underlying such information) and cannot be relied upon as a guarantee of future performance. Due to various risks and uncertainties, actual events or results, or the actual performance of any fund may differ materially from those reflected or contemplated in such forward-looking statements.


Eastspring Investments companies (excluding JV companies) are ultimately wholly-owned / indirect subsidiaries / associate of Prudential plc of the United Kingdom. Eastspring Investments companies (including JV’s) and Prudential plc are not affiliated in any manner with Prudential Financial, Inc., a company whose principal place of business is in the United States of America.